AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (4.9 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access | Online First

SDRec: Synergistic Drug Recommendation Network Based on Medical Domain Knowledge

School of Information Science and Technology, Dalian Maritime University, Dalian 116024, China
School of Artificial Intelligence, Dalian Maritime University, Dalian 116024, China
Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305, USA
Show Author Information

Abstract

Drug recommendation is a prominent topic in the medical field, aiming to suggest a set of safe drug combinations based on patients’ clinical information and medical knowledge. Existing research has primarily focused on utilizing patients’ electronic health records (EHRs) and avoiding adverse drug-drug interaction (ADDI) for drug recommendation. However, they ignore the influence of drug synergy in the recommendation system. To address this limitation, we propose the synergistic drug recommendation network based on medical domain knowledge (SDRec), which introduces the concept of drug synergy into the field for the first time. Specifically, we design a drug synergy module that extracts drug features from the perspective of molecular structures and models the interaction information between different drug pairs to provide safe and effective drug combinations for patients. Additionally, we incorporate a drug synergy graph derived from medical domain knowledge and model it using a graph convolutional network. Considering the safety of the recommended drug, we introduce a contrastive loss function during training to balance the features of drug synergy and adverse drug reactions, thereby minimizing potential side effects. Our experimental findings indicate that SDRec achieves notable performance enhancements compared to several baseline methods on the MIMIC-III and MIMIC-IV datasets.

References

【1】
【1】
 
 
Tsinghua Science and Technology

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
An K, Lu M, Chen F, et al. SDRec: Synergistic Drug Recommendation Network Based on Medical Domain Knowledge. Tsinghua Science and Technology, 2026, https://doi.org/10.26599/TST.2025.9010078

365

Views

9

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 29 November 2024
Revised: 19 January 2025
Accepted: 07 May 2025
Published: 14 September 2026
© The author(s) 2026.

The articles published in this open access journal are distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/).